Development and validation of a RP–HPLC method for quantization studies of albendazole suspension dosage forms of Rombendazol

An isocratic high-performance liquid chromatography (HPLC) procedure was developed and validated for the quantitative determination of albendazole in suspension of Rombendazole. HPLC separation was carried out by reversed phase chromatography on Kromasil C18 (150 mm x 4.6 mm i.e.; 5 μm particle size...

Full description

Saved in:
Bibliographic Details
Main Authors: Elena Gabriela Oltean, Nica A.
Format: Article
Language:English
Published: Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar 2011-12-01
Series:Medicamentul Veterinar
Subjects:
Online Access:http://www.veterinarypharmacon.com/docs/998-2011-ART.%205.%20eng.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An isocratic high-performance liquid chromatography (HPLC) procedure was developed and validated for the quantitative determination of albendazole in suspension of Rombendazole. HPLC separation was carried out by reversed phase chromatography on Kromasil C18 (150 mm x 4.6 mm i.e.; 5 μm particle size), held in thermostat at 25°C. The mobile phase consisted of Methanol/ Distilled water (65/35 v/v), with a flow rate of 1.2 ml/ min and UV detection at 308 nm. In order to validate the method, the following parameters have been investigated - linearity (r2=0.9999), range, precision, accuracy, specificity, limit of detection LOD and limit of quantification LOQ. The described method can be successfully applied for the analysis of the active pharmaceutical compound in suspensions.
ISSN:1843-9527
2069-2463